BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20978204)

  • 1. Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKL.
    Yang Y; Ren Y; Ramani VC; Nan L; Suva LJ; Sanderson RD
    Cancer Res; 2010 Nov; 70(21):8329-38. PubMed ID: 20978204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High heparanase activity in multiple myeloma is associated with elevated microvessel density.
    Kelly T; Miao HQ; Yang Y; Navarro E; Kussie P; Huang Y; MacLeod V; Casciano J; Joseph L; Zhan F; Zangari M; Barlogie B; Shaughnessy J; Sanderson RD
    Cancer Res; 2003 Dec; 63(24):8749-56. PubMed ID: 14695190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparanase inhibits osteoblastogenesis and shifts bone marrow progenitor cell fate in myeloma bone disease.
    Ruan J; Trotter TN; Nan L; Luo R; Javed A; Sanderson RD; Suva LJ; Yang Y
    Bone; 2013 Nov; 57(1):10-7. PubMed ID: 23895995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis.
    Sanderson RD; Yang Y; Suva LJ; Kelly T
    Matrix Biol; 2004 Oct; 23(6):341-52. PubMed ID: 15533755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of AKT protein in myeloma-induced osteoclast formation and osteolysis.
    Cao H; Zhu K; Qiu L; Li S; Niu H; Hao M; Yang S; Zhao Z; Lai Y; Anderson JL; Fan J; Im HJ; Chen D; Roodman GD; Xiao G
    J Biol Chem; 2013 Oct; 288(42):30399-30410. PubMed ID: 24005670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease.
    Giuliani N; Colla S; Sala R; Moroni M; Lazzaretti M; La Monica S; Bonomini S; Hojden M; Sammarelli G; Barillè S; Bataille R; Rizzoli V
    Blood; 2002 Dec; 100(13):4615-21. PubMed ID: 12393684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma.
    Yang J; He J; Wang J; Cao Y; Ling J; Qian J; Lu Y; Li H; Zheng Y; Lan Y; Hong S; Matthews J; Starbuck MW; Navone NM; Orlowski RZ; Lin P; Kwak LW; Yi Q
    Leukemia; 2012 Sep; 26(9):2114-23. PubMed ID: 22425892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloma cells can directly contribute to the pool of RANKL in bone bypassing the classic stromal and osteoblast pathway of osteoclast stimulation.
    Lai FP; Cole-Sinclair M; Cheng WJ; Quinn JM; Gillespie MT; Sentry JW; Schneider HG
    Br J Haematol; 2004 Jul; 126(2):192-201. PubMed ID: 15238139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of MCP-1 and RANKL.
    Ohba T; Cole HA; Cates JM; Slosky DA; Haro H; Ando T; Schwartz HS; Schoenecker JG
    J Bone Miner Res; 2014 Jun; 29(6):1431-45. PubMed ID: 24443409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HGF/Met/NF-κB Pathway Regulates RANKL Expression in Osteoblasts and Bone Marrow Stromal Cells.
    Tsubaki M; Seki S; Takeda T; Chihara A; Arai Y; Morii Y; Imano M; Satou T; Shimomura K; Nishida S
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases.
    Kelly T; Suva LJ; Huang Y; Macleod V; Miao HQ; Walker RC; Sanderson RD
    Cancer Res; 2005 Jul; 65(13):5778-84. PubMed ID: 15994953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immature dendritic cells from patients with multiple myeloma are prone to osteoclast differentiation in vitro.
    Tucci M; Ciavarella S; Strippoli S; Brunetti O; Dammacco F; Silvestris F
    Exp Hematol; 2011 Jul; 39(7):773-83.e1. PubMed ID: 21569821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis.
    Grimaud E; Soubigou L; Couillaud S; Coipeau P; Moreau A; Passuti N; Gouin F; Redini F; Heymann D
    Am J Pathol; 2003 Nov; 163(5):2021-31. PubMed ID: 14578201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma.
    Qiang YW; Chen Y; Stephens O; Brown N; Chen B; Epstein J; Barlogie B; Shaughnessy JD
    Blood; 2008 Jul; 112(1):196-207. PubMed ID: 18305214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression and shedding of receptor activator of NF-kappaB ligand during tumor-bone interaction potentiates mammary tumor-induced osteolysis.
    Nannuru KC; Futakuchi M; Sadanandam A; Wilson TJ; Varney ML; Myers KJ; Li X; Marcusson EG; Singh RK
    Clin Exp Metastasis; 2009; 26(7):797-808. PubMed ID: 19590968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors.
    Yamagishi T; Kawashima H; Ogose A; Ariizumi T; Sasaki T; Hatano H; Hotta T; Endo N
    PLoS One; 2016; 11(5):e0154680. PubMed ID: 27163152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
    Giuliani N; Colla S; Morandi F; Rizzoli V
    Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ewing sarcoma cells express RANKL and support osteoclastogenesis.
    Taylor R; Knowles HJ; Athanasou NA
    J Pathol; 2011 Oct; 225(2):195-202. PubMed ID: 21547906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparanase promotes the spontaneous metastasis of myeloma cells to bone.
    Yang Y; Macleod V; Bendre M; Huang Y; Theus AM; Miao HQ; Kussie P; Yaccoby S; Epstein J; Suva LJ; Kelly T; Sanderson RD
    Blood; 2005 Feb; 105(3):1303-9. PubMed ID: 15471949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.